Phase 4 Acute Coronary Syndromes Clinical Trials
6 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–6 of 6 trials
Recruiting
Phase 4
Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia
Coronary Artery EctasiaSTEMI - ST Elevation Myocardial InfarctionNSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)+1 more
Instituto Nacional de Cardiologia Ignacio Chavez326 enrolled1 locationNCT07511257
Recruiting
Phase 4
Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome
Elderly (People Aged 65 or More)Iron Deficienciesacute coronary syndromes (ACS)
Fundación para la Investigación del Hospital Clínico de Valencia538 enrolled9 locationsNCT07476859
Recruiting
Phase 4
Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques
Coronary Arterial Disease (CAD)Vulnerable Coronary PlaquesThin-cap fIbroatheroma+1 more
Beijing Anzhen Hospital2,190 enrolled1 locationNCT06855537
Recruiting
Phase 4
Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome
Acute Coronary Syndromes
King Edward Medical University152 enrolled1 locationNCT06765265
Recruiting
Phase 4
Biomarker-guided Management Following a Heart Attack
Secondary prevention post-acute coronary syndromesCardiovascular Disease
Professor Rob Doughty1,028 enrolled1 locationACTRN12619001445167
Completed
Phase 4
THE IMPACT OF THREE DIFFERENT GLYCOPROTEIN PLATELET RECEPTOR IIb/IIIa ANTAGONISTS ON GLYCOPROTEIN IIb/IIIa PLATELET RECEPTOR INHIBITION AND CLINICAL ENDPOINTS IN PATIENTS WITH ACUTE CORONARY SYNDROMES
Assessing patients presenting with acute coronary syndromes, aiming to reduce adverse cardiac outcomes.
A/Professor Craig Juergens210 enrolled1 locationACTRN12607000328471